Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China · Delayed Price · Currency is CNY 23.18
0.00 (0.00%)
Apr 21, 2026, 3:04 PM CST
SHE:002287 Market Cap
SHE:002287 has a market cap or net worth of 13.2 billion as of April 20, 2026. Its market cap has increased by 13.08% in one year.
Market Cap
13.20B
Enterprise Value
11.21B
Revenue
2.42B
Ranking
n/a
PE Ratio
19.50
Stock Price
23.18
Market Cap Chart
Since September 3, 2009, SHE:002287's market cap has increased from 7.26B to 13.20B, an increase of 81.73%. That is a compound annual growth rate of 3.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 13.20B | -2.03% |
| Dec 31, 2025 | 13.47B | 18.75% |
| Dec 31, 2024 | 11.35B | -4.85% |
| Dec 29, 2023 | 11.92B | -1.14% |
| Dec 30, 2022 | 12.06B | -25.24% |
| Dec 31, 2021 | 16.13B | 17.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inner Mongolia Furui Medical Science | 15.10B |
| Staidson (Beijing) BioPharmaceuticals | 14.49B |
| Chengzhi | 12.97B |
| Vcanbio Cell & Gene Engineering Corp., | 12.91B |
| InventisBio | 12.76B |
| Pacific Shuanglin Bio-pharmacy | 12.27B |
| Hualan Biological Vaccine | 11.85B |
| Chengdu Olymvax Biopharmaceuticals | 11.81B |